REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/10/2026
Back to search
Official data from USPTO
RYSDERO MYCITE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RYSDERO MYCITE
ST13
US500000079292747Class
5, 10
Filing
79292747
Registration
6443521
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/10/2026
Trademark type
Word
Nice classes
5, 10
Filing date
06/24/2020
Registration date
08/10/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/10/2021
Last transaction
08/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
REINHART, MEGHAN M
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Otsuka Pharmaceutical Co., Ltd.
Representatives
Scott S. Havlick Holland & Hart LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders in the form of ingestible tablets and pills containing silicon sensor chips; pharmaceutical preparations for the treatment of central nervous system diseases and disorderscontaining silicon sensor chips which transmit information about drug ingestion by the patient
Class 10
Medical apparatus and instruments for monitoring vital signs of patients; medical diagnostic apparatus and instruments for monitoring vital signs of patients; patient monitoring sensors and alarms; sensor apparatus for medical use in monitoring the vital signs of patients; sensor devices and medical apparatus all for medical usesensor patches attached to a patient's body for use in measuringcollectingstoring and transmitting patient data and medical information in the nature of drug ingestion informationpulseheart raterespiratory ratebody temperatureelectric pressure in the bodyhuman motionhuman position and sleeping condition
Publications
History of USPTO decisions and trademark events.
30 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/13/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/06/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/18/2022
FIMP
FINAL DISPOSITION PROCESSED
01/18/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/10/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/10/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/25/2021
PUBO
PUBLISHED FOR OPPOSITION
05/25/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/23/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/05/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/05/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/16/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/16/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/15/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/15/2021
RFNT
REFUSAL PROCESSED BY IB
12/06/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/13/2020
RFRR
REFUSAL PROCESSED BY MPU
11/13/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/27/2020
CNRT
NON-FINAL ACTION WRITTEN
10/26/2020
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
10/23/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/01/2020
CNRT
NON-FINAL ACTION WRITTEN
09/30/2020
DOCK
ASSIGNED TO EXAMINER
09/27/2020
MAFR
APPLICATION FILING RECEIPT MAILED
09/15/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/11/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/08/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/03/2020
Continuous trademark protection
Get notified about every new filing that threatens RYSDERO MYCITE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.